Filed: 2/13/2024ACC: 0001697228-24-000001
📋 What this filing means
UNIVERSITY OF WISCONSIN FOUNDATION filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $60.10M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$60.10M
Total AUM (reported)
2.52M
Total Shares
Allocation by class
COM$27.12M45.1%
CORE S&P500 ETF$17.08M28.4%
ORD SHS CL A$15.90M26.5%
Portfolio Concentration
Top 3$49.99M83.2%
4–10$10.11M16.8%
Top 3 weight
83.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.52M
Sole
Full voting authority
2.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ISHARES TR
SOLEShares35.76K
TypeSH
Market value$17.08M
28.42%
Sole
35.76K
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares73.49K
TypeSH
Market value$17.00M
28.29%
Sole
73.49K
Shared
0.00
None
0.00
NU HLDGS LTD
SOLEShares1.91M
TypeSH
Market value$15.90M
26.46%
Sole
1.91M
Shared
0.00
None
0.00
AKERO THERAPEUTICS INC
SOLEShares372.57K
TypeSH
Market value$8.70M
14.48%
Sole
372.57K
Shared
0.00
None
0.00
89BIO INC
SOLEShares126.52K
TypeSH
Market value$1.41M
2.35%
Sole
126.52K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ISHARES TRSOLE | CORE S&P500 ETF | 35.76K | SH | $17.08M 28.42% | 35.76K | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 73.49K | SH | $17.00M 28.29% | 73.49K | 0.00 | 0.00 |
NU HLDGS LTDSOLE | ORD SHS CL A | 1.91M | SH | $15.90M 26.46% | 1.91M | 0.00 | 0.00 |
AKERO THERAPEUTICS INCSOLE | COM | 372.57K | SH | $8.70M 14.48% | 372.57K | 0.00 | 0.00 |
89BIO INCSOLE | COM | 126.52K | SH | $1.41M 2.35% | 126.52K | 0.00 | 0.00 |